This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Charlotte, NC-based Albemarle Corporation is a premier specialty chemicals company with leading positions in attractive end markets globally. It is a leading producer of highly-engineered specialty chemicals geared to meet customer requirements across a bevy of end markets including petroleum refining, consumer electronics, energy storage, construction and automotive.
Huntsman's (HUN) Earnings and Revenues Top Estimates in Q4
by Zacks Equity Research
Huntsman's (HUN) Q4 results benefit from higher sales across all segments in the quarter.
The Andersons (ANDE) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Andersons (ANDE) delivered earnings and revenue surprises of 96.55% and 44.05%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
BHP Group (BHP) Earnings Up Y/Y in First Half of Fiscal 2022
by Zacks Equity Research
BHP Group Limited's (BHP) earnings in the first half of fiscal 2022 gain on higher prices and near-record iron-ore production volumes.
Cleveland-Cliffs' (CLF) Earnings & Sales Miss Estimates in Q4
by Zacks Equity Research
Cleveland-Cliffs (CLF) sees sequentially lower shipments in Q4 as automotive production remained light due to supply-chain issues. It envisions higher steel selling prices in 2022.
ArcelorMittal's (MT) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
ArcelorMittal's (MT) Q4 results benefit from higher average steel pricing. The company raises dividends and announces a new $1-billion share buyback program.
U.S. Steel (X) Breaks Ground on $3B Steel Mill in Arkansas
by Zacks Equity Research
U.S. Steel (X) starts constructing a highly sustainable and state-of-the-art steel mill which will be the largest private project in the history of Arkansas.
Chemours (CC) Earnings Miss Estimates, Revenues Top in Q4
by Zacks Equity Research
Volumes and prices contributed favorably to Chemours' (CC) top-line growth in the fourth quarter. It sees adjusted earnings per share in the band of $4.07-$4.70 for 2022.
Albemarle (ALB) Stock Moves -0.16%: What You Should Know
by Zacks Equity Research
In the latest trading session, Albemarle (ALB) closed at $236.04, marking a -0.16% move from the previous day.
Linde (LIN) Q4 Earnings Beat on Higher Prices & Volumes
by Zacks Equity Research
Increased prices and volumes from electronics, energy and chemicals end markets primarily drove Linde's (LIN) Q4 earnings.
Eastman (EMN) Provides Kingsport Incident Update & Q1 View
by Zacks Equity Research
Eastman Chemical (EMN) forecasts first-quarter earnings per share in the range of $2.05-$2.25.
Ashland (ASH) Rolls Out ISO 10993 Compliant PSA Platform
by Zacks Equity Research
Ashland's (ASH) recently-launched product portfolio consists of seven highly competitive Aroset and Flexcryl acrylic PSAs developed for challenging applications.
Albemarle (ALB) to Post Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from higher volumes and pricing in its lithium business and its cost and productivity actions in the fourth quarter.
Analysts Estimate Albemarle (ALB) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Albemarle (ALB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sherwin-Williams (SHW) Inks Deal to Boost Capacity in Statesville
by Zacks Equity Research
Sherwin-Williams (SHW) plans to invest a minimum of $300 million in the Statesville project, creating more than 180 jobs at the site over the next three years.
Avient's (AVNT) Q4 Earnings and Sales Surpass Estimates
by Zacks Equity Research
Avient (AVNT) benefits from higher demand for sustainable solutions, healthcare applications and composites technologies amid headwinds from raw material and supply-chain disruptions in Q4.
FMC Corp's (FMC) Earnings and Sales Top Estimates in Q4
by Zacks Equity Research
FMC Corp's (FMC) Q4 results benefit from a healthy demand environment and accelerating price increases.
DuPont's (DD) Earnings and Revenues Trounce Estimates in Q4
by Zacks Equity Research
DuPont (DD) benefits from strong demand in semiconductors and water technologies and continued recovery in industrial markets in Q4. It raised its dividend by 10% and announced a new $1 billion buyback program.
PPG to Enrich Portfolio on Arsonsisi's Powder Coating Unit Buyout
by Zacks Equity Research
The inclusion of Arsonsisi's powder coating division will boost PPG's sustainable coatings capability and will offer its EMEA customers expanded powder coating options.
Nucor (NUE) Wraps Up California Steel Buyout, Boosts Portfolio
by Zacks Equity Research
Nucor's (NUE) acquisition boosts its presence in the Western region and enhances its ability to produce a wider range of value-added sheet products.
Eastman (EMN) Boosts Tertiary Amine Capacity in Ghent & Pace
by Zacks Equity Research
Eastman's (EMN) investments to expand its tertiary amine capacity showcase its strong commitment to its home and personal care customers.
Air Products' (APD) Q1 Earnings and Sales Surpass Estimates
by Zacks Equity Research
Air Products' (APD) Q1 results benefit from higher volumes and pricing as well as increased energy cost pass-through.
Allegheny (ATI) Earnings and Revenues Beat Estimates in Q4
by Zacks Equity Research
Allegheny's (ATI) fourth-quarter results benefit from strong sales in the HPMC unit, improved mix and cost-reduction measures.
Hawkins (HWKN) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Hawkins' (HWKN) Q3 top line was driven by higher volumes across the Industrial and Water Treatment segments in most end-markets.
U.S. Silica (SLCA) Raises Industrial & Specialty Products Prices
by Zacks Equity Research
U.S. Silica (SLCA) decides to raise prices of Industrial & Specialty Products to counter the increasing costs of raw materials and other expenses.
Albemarle (ALB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Albemarle (ALB) closed at $221.49 in the latest trading session, marking a -1.65% move from the prior day.